We found that the downregulation of LCN2 alleviated sepsis-related cognitive impairments (sFig. 6B–E) and synaptic dysfunction (sFig. 6F–H) 2 weeks after intraperitoneal injection of LPS (sFig. 6A). The gene discussed is LCN2; the disease is Sepsis.